35 related articles for article (PubMed ID: 11939727)
1. Metastatic ovarian papillary cystadenocarcinoma to the small intestine serous surface: report of a case of high-grade histopathologic malignancy.
Khaki F; Javanbakht J; Sharifzad S; Gharagozlou MJ; Khadivar F; Manesh JY; Hosseini SH; Anissian A; Touni SR; Gilvari A; Abdi FS
J Ovarian Res; 2014 Mar; 7():33. PubMed ID: 24636424
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer during fertility follow-up.
Jiménez A; Chiva L
Int J Gynecol Cancer; 2024 Mar; ():. PubMed ID: 38531537
[No Abstract] [Full Text] [Related]
3. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma.
Al-Hussaini M; Stockman A; Foster H; McCluggage WG
Histopathology; 2004 Feb; 44(2):109-15. PubMed ID: 14764054
[TBL] [Abstract][Full Text] [Related]
4. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.
Acs G; Pasha T; Zhang PJ
Int J Gynecol Pathol; 2004 Apr; 23(2):110-8. PubMed ID: 15084838
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas.
Zhang Y; Garcia-Buitrago MT; Koru-Sengul T; Schuman S; Ganjei-Azar P
Int J Gynecol Pathol; 2013 Sep; 32(5):476-81. PubMed ID: 23896709
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
Egan JA; Ionescu MC; Eapen E; Jones JG; Marshall DS
Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
[TBL] [Abstract][Full Text] [Related]
7. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
8. Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus.
Verma R; Venkatareddy M; Kalinowski A; Li T; Kukla J; Mollin A; Cara-Fuentes G; Patel SR; Garg P
PLoS One; 2018; 13(6):e0198013. PubMed ID: 29924795
[TBL] [Abstract][Full Text] [Related]
9. RNF8 and SCML2 cooperate to regulate ubiquitination and H3K27 acetylation for escape gene activation on the sex chromosomes.
Adams SR; Maezawa S; Alavattam KG; Abe H; Sakashita A; Shroder M; Broering TJ; Sroga Rios J; Thomas MA; Lin X; Price CM; Barski A; Andreassen PR; Namekawa SH
PLoS Genet; 2018 Feb; 14(2):e1007233. PubMed ID: 29462142
[TBL] [Abstract][Full Text] [Related]
10. AHR regulates WT1 genetic programming during murine nephrogenesis.
Falahatpisheh MH; Nanez A; Ramos KS
Mol Med; 2011; 17(11-12):1275-84. PubMed ID: 21863216
[TBL] [Abstract][Full Text] [Related]
11. The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis.
Menke AL; IJpenberg A; Fleming S; Ross A; Medine CN; Patek CE; Spraggon L; Hughes J; Clarke AR; Hastie ND
J Pathol; 2003 Aug; 200(5):667-74. PubMed ID: 12898605
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
13. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
14. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
15. My approach to and thoughts on the typing of ovarian carcinomas.
McCluggage WG
J Clin Pathol; 2008 Feb; 61(2):152-63. PubMed ID: 17704261
[TBL] [Abstract][Full Text] [Related]
16. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas.
Goldstein NS; Uzieblo A
Am J Clin Pathol; 2002 Apr; 117(4):541-5. PubMed ID: 11939727
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps.
Euscher ED; Malpica A; Deavers MT; Silva EG
Am J Surg Pathol; 2005 Aug; 29(8):1074-8. PubMed ID: 16006803
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
